Glenmark Pharmaceuticals on Wednesday said it has received tentative approval from the US health regulator for its generic Dapagliflozin and Saxagliptin anti-diabetes tablets.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cYys8g
via IFTTT
0 comments:
Post a Comment